Doxylamine succinate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diltiazem HCl. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes dimenhydrinate. It belongs to antiemetic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diphenihydramine HCl. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diphenydramine HCl + caffeine. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diphenylpiraline HCI. It belongs to antihistamine category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes doxycicline base. It belongs to antibacterial category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes doxylamine succinate + pyridoxine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes etofibrate. It belongs to antihyperlipoproteinemic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes fenofibrate. It belongs to antihyperlipoproteinemic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous fumarate. It belongs to Fe deficiency category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous sulfate + folic acid. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous sulfate + folic acid + Zn. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.